Bristol-Myers Squibb shares rise as Q2 results boosted by growth portfolio
Yahoo Financearrow_outwardBristol Myers Beats Earnings Expectations. Itโs Still Optimistic About New Schizophrenia Drug.
Barron'sarrow_outwardBristol Myers Squibb Cuts Full-Year Adjusted View, But Raises Revenue Expectations
The Wall Street Journalarrow_outwardBristol-Myers Squibb Q2 2025 Financial Results Released - TipRanks
TipRanksarrow_outwardBristol-Myers delivers double beat and raises full-year sales forecast (BMY:NYSE) - Seeking Alpha
Seeking Alphaarrow_outwardLatest Q2 2025 Financial Results: Bristol Myers Squibb Releases Earnings Report and Investor Call Details - Stock Titan
Stock Titanarrow_outwardGoldman Sachs Maintains a Hold on Bristol-Myers Squibb (BMY) - MSN
MSNarrow_outward(BMY) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
News.stocktradersdaily.comarrow_outwardBristol Myers Squibb: A Stock with Potential Amid Challenges - The Motley Fool
The Motley Foolarrow_outwardHow Will Bristol Myers Squibb Stock React To Its Upcoming Earnings? - Forbes
Forbesarrow_outwardOctober 17th Options Now Available For Bristol Myers Squibb (BMY) - Nasdaq
Nasdaqarrow_outwardBristol-Myers Squibb stock unchanged as Cantor Fitzgerald maintains Neutral rating - Investing.com India
Investing.com Indiaarrow_outwardShould You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings? - Zacks Investment Research
Zacks Investment Researcharrow_outwardBristol-Myers Squibb Appoints New Chief Medical Officer - The Globe and Mail
The Globe and Mailarrow_outwardBristol Myers (BMY) Appoints New Chief Medical Officer | BMY Stock News - GuruFocus
GuruFocusarrow_outwardShareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested three years ago - simplywall.st
Simplywall.starrow_outwardBristol Myers Squibb Stock (BMY) Opinions on Phase 3 Trial Results - Quiver Quantitative
Quiver Quantitativearrow_outwardBristol Myers Squibb Co. stock underperforms Friday when compared to competitors - MarketWatch
MarketWatcharrow_outwardBristol Myers Squibb (BMY): A Contrarian Play Amid Sector Headwinds? - AInvest
AInvestarrow_outwardThis Once Dominant Dividend Stock May Be About to Come Back to Life in July - 24/7 Wall St.
24/7 Wall St.arrow_outwardThe Top 5 Analyst Questions From Bristol-Myers Squibbโs Q1 Earnings Call - FinancialContent
FinancialContentarrow_outwardBioNTech Stock Jumps on Bristol Myers Squibb Cancer Drug Collaboration - Investopedia
Investopediaarrow_outwardBMO maintains Bristol-Myers Squibb stock at Market Perform - Investing.com
Investing.comarrow_outwardBristol Myers Squibb Reverses Its Losing Spree On First-Quarter Beat - Investor's Business Daily
Investor's Business Dailyarrow_outwardIs Bristol-Myers Squibb Stock A Safe Haven During Tariff Turmoil? - Trefis
Trefisarrow_outward
Bmy Stock close
- 2025-07-31 20:00 event
- 25 sourceslanguage
- 100+ ads_click
- 23 hours ago schedule